These effects likely arise through resveratrol’s modulation of GnRH pulsatility and steroidogenic enzyme activity, highlighting its potential to disrupt the self-reinforcing hormonal imbalances central to PCOS pathophysiology. This evidence concerns the gene GNRH1 and polycystic ovary syndrome.